GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (OTCPK:SSMXY) » Definitions » Scaled Net Operating Assets

SSMXY (Sysmex) Scaled Net Operating Assets : N/A (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Sysmex Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Sysmex's operating assets for the quarter that ended in Sep. 2024 was $3,673 Mil. Sysmex's operating liabilities for the quarter that ended in Sep. 2024 was $844 Mil. Sysmex's Total Assets for the quarter that ended in Jun. 2024 was $0 Mil. Therefore, Sysmex's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was N/A.


Sysmex Scaled Net Operating Assets Historical Data

The historical data trend for Sysmex's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex Scaled Net Operating Assets Chart

Sysmex Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.73 0.66 0.64 0.63 0.69

Sysmex Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.67 0.73 0.70 - -

Competitive Comparison of Sysmex's Scaled Net Operating Assets

For the Medical Instruments & Supplies subindustry, Sysmex's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sysmex's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sysmex's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Sysmex's Scaled Net Operating Assets falls into.



Sysmex Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Sysmex's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2024 )
=(Operating Assets (A: Mar. 2024 )-Operating Liabilities (A: Mar. 2024 ))/Total Assets (A: Mar. 2023 )
=(3618.396-872.281)/3973.193
=0.69

where

Operating Assets(A: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4131.129 - 512.733
=3618.396

Operating Liabilities(A: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1241.655 - 311.577 - 57.797
=872.281

Sysmex's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(3672.916-844.083)/0
=N/A

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4323.496 - 650.58
=3672.916

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1233.551 - 330.974 - 58.494
=844.083

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sysmex Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Sysmex's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Sysmex Business Description

Traded in Other Exchanges
Address
1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex Headlines

From GuruFocus

Q2 2020 Sysmex Corp Earnings Presentation Transcript

By GuruFocus Research 02-15-2024

Matthews Japan Fund Q4 2014 Commentary

By Vera Yuan Vera Yuan 02-05-2015

Matthews Japan Fund Comments on Sysmex

By Vera Yuan Vera Yuan 02-05-2015

Q1 2020 Sysmex Corp Earnings Call Transcript

By GuruFocus Research 02-15-2024

Matthews Japan Fund Comments on Sysmex

By Sydnee Gatewood Sydnee Gatewood 10-21-2020

Vanguard Health Care Fund Gains 4 International Stocks in 2nd Quarter

By Sydnee Gatewood Sydnee Gatewood 08-04-2017

Q3 2020 Sysmex Corp Earnings Call Transcript

By GuruFocus Research 02-15-2024